产品详情
Targets
Target | Value |
---|---|
FGFR1 | IC50: 0.2nM |
FGFR3 | IC50: 1.8nM |
FGFR2 | IC50: 2.5nM |
KDR | IC50: 24nM |
FGFR4 | IC50: 165nM |
IGFR | IC50: 581nM |
Axl | IC50: >2μM |
CDK2 | IC50: >10μM |
FAK | IC50: >10μM |
ROCK2 | IC50: >50μM |
Akt1 | IC50: >100μM |
ALK1 | IC50: >100μM |
p38 | IC50: >100μM |
PI3Kα | IC50: >100μM |
In vitro (25°C) | DMSO | 79 mg/mL (170.41 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 4% DMSO+30% PEG 300+5% Tween 80+ddH2O | 4 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.57 mL | 107.85 mL | 215.7 mL |
0.5 mM | 4.31 mL | 21.57 mL | 43.14 mL |
1 mM | 2.16 mL | 10.79 mL | 21.57 mL |
5 mM | 0.43 mL | 2.16 mL | 4.31 mL |
*The above data is based on the productmolecular weight 463.6. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A11075 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 463.6 |
Formula | C26H33N5O3 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 1035270-39-3 |
Synonyms | AZD-4547 |
SMILES | C[C@@H]1CN(C[C@@H](N1)C)C2=CC=C(C=C2)C(=O)NC3=NNC(=C3)CCC4=CC(=CC(=C4)OC)OC |
产品标签
Product Questions
Product Questions
Alofanib (RPT835)
Alofanib (RPT835)是FGFR2的强效选择性变构抑制剂,具有潜在的抗癌活性。
Pazopanib (GW-786034)
Pazopanib (GW-786034)是VEGFR-1,VEGFR-2,VEGFR-3,PDGFR-a/β和c-kit的有效且选择性的多靶点酪氨酸激酶抑制剂,可阻…
Pazopanib HCl (GW786034)
Pazopanib HCl (GW786034)是VEGFR-1,VEGFR-2,VEGFR-3,PDGFR-a/β和c-kit的有效且选择性的多靶点酪氨酸激酶抑制剂,可…
NVP-BGJ398 phosphate
NVP-BGJ398 phosphate是一种新型的选择性泛特异性FGFR抑制剂,对FGFR1,FGFR2和FGFR3的IC50分别为0.9、1.4和1 nM。与FGF…
Debio-1347 (CH5183284)
Debio-1347 (CH5183284)是成纤维细胞生长因子受体亚型1(FGFR-1),2(FGFR-2)和3(FGFR-3)的生物利用抑制剂,具…
Erdafitinib (JNJ-42756493)
Erdafitinib (JNJ-42756493)是一种有效且选择性的口服生物利用型泛成纤维细胞生长因子受体(FGFR)抑制剂,具…
LY 2874455
LY2874455是一种新型有效的FGFR / VEGFR抑制剂。